| 9925189 |
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
Xin Chen, Peng Cheng, L. Edward Clemens, Jeffrey D. Johnson, Jingyuan Ma +6 more |
2018-03-27 |
| 9737537 |
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
Xin Chen, Peng Cheng, L. Edward Clemens, Jeffrey D. Johnson, Jingyuan Ma +6 more |
2017-08-22 |
| 8975258 |
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
Xin Chen, Peng Cheng, L. Edward Clemens, Jeffrey D. Johnson, Jingyuan Ma +6 more |
2015-03-10 |
| 8921350 |
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
Xin Chen, Peng Cheng, L. Edward Clemens, Jeffrey D. Johnson, Jingyuan Ma +6 more |
2014-12-30 |
| 8288384 |
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
Xin Chen, Peng Cheng, L. Edward Clemens, Jeffrey D. Johnson, Jingyuan Ma +6 more |
2012-10-16 |
| 8227495 |
2,4-disubsituted thiazoles and pharmaceutical compositions thereof |
Xin Chen, Peng Cheng, L. Edward Clemens, Jeffrey D. Johnson, Jingyuan Ma +6 more |
2012-07-24 |
| 7638541 |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
Xin Chen, Peng Cheng, L. Edward Clemens, Jeffrey D. Johnson, Jingyuan Ma +6 more |
2009-12-29 |
| 7556930 |
CD39L3 and its role in diabetes |
Jeffrey D. Johnson, Yuko Terasawa |
2009-07-07 |